<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A retrospective study of acquired <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in 100 Thai children treated with <z:chebi fb="51" ids="17347">testosterone</z:chebi> and <z:chebi fb="2" ids="8378">prednisolone</z:chebi> during 1969 to 1987 is reported </plain></SENT>
<SENT sid="1" pm="."><plain>The age ranged from 3-14.5 years (mean 10.3 years) </plain></SENT>
<SENT sid="2" pm="."><plain>The male to female ratio was 2.3:1 </plain></SENT>
<SENT sid="3" pm="."><plain>The duration of follow up ranged from 1-17 year (mean 5 years) </plain></SENT>
<SENT sid="4" pm="."><plain>Prior exposure to possible etiologic agents was found in 36% : <z:chebi fb="0" ids="35493">antipyretics</z:chebi>, Ya-chood, <z:chebi fb="57" ids="24852">insecticides</z:chebi>, <z:chebi fb="56" ids="16716">benzene</z:chebi>, <z:chebi fb="0" ids="17698">chloramphenicol</z:chebi> and paint </plain></SENT>
<SENT sid="5" pm="."><plain>The presenting symptoms were <z:mp ids='MP_0001914'>bleeding</z:mp> and <z:hpo ids='HP_0001903'>anemia</z:hpo> 72%, <z:hpo ids='HP_0001945'>fever</z:hpo> with either <z:mp ids='MP_0001914'>bleeding</z:mp> or <z:hpo ids='HP_0001903'>anemia</z:hpo> 28% </plain></SENT>
<SENT sid="6" pm="."><plain>The common sites of <z:mp ids='MP_0001914'>bleeding</z:mp> were <z:hpo ids='HP_0000979'>purpura</z:hpo>, <z:hpo ids='HP_0000421'>epistaxis</z:hpo>, gum and teeth, and the gastrointestinal tract </plain></SENT>
<SENT sid="7" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients received appropriate supportive treatment and <z:chebi fb="51" ids="17347">testosterone</z:chebi> combined with <z:chebi fb="2" ids="8378">prednisolone</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>The results of treatment were evaluated in 80 cases who were followed up until <z:hpo ids='HP_0011420'>death</z:hpo> or at least one year after the diagnosis </plain></SENT>
<SENT sid="9" pm="."><plain>Two-thirds of the patients presented with laboratory findings similar to severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo>; the fatality rate was 50% (40/80) </plain></SENT>
<SENT sid="10" pm="."><plain>Most of them succumbed to <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> or <z:mp ids='MP_0001914'>bleeding</z:mp> in the first 6 months after diagnosis </plain></SENT>
<SENT sid="11" pm="."><plain>The recovery rate was 50% with complete, partial and initial responses in 28%, 17% and 5% respectively </plain></SENT>
<SENT sid="12" pm="."><plain>The late <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> rate was 2% </plain></SENT>
<SENT sid="13" pm="."><plain>For severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> or for patients who have poor prognostic factors, early approaches of bone marrow transplantation or antilymphocyte globulin administration should be considered </plain></SENT>
</text></document>